miR Scientific announces commercial launch of miR Sentinel
miR Sentinel is designed to evaluate the risk of aggressive prostate cancer.

miR Sentinel is designed to evaluate the risk of aggressive prostate cancer.
Quidel has partnered with drugstore chain Walgreens to make QuickVue at-home rapid antigen tests available without a prescription.
Thank you for subscribing to Medical Device Network